Please use this identifier to cite or link to this item: https://hdl.handle.net/11000/38555
Full metadata record
DC FieldValueLanguage
dc.contributor.authordos Santos, Reinaldo S.-
dc.contributor.authorBabiloni Chust, Ignacio-
dc.contributor.authorMarroqui Esclapez, Laura-
dc.contributor.authorNadal, Angel-
dc.contributor.otherDepartamentos de la UMH::Fisiologíaes_ES
dc.date.accessioned2025-11-27T13:25:33Z-
dc.date.available2025-11-27T13:25:33Z-
dc.date.created2022-
dc.identifier.citationInternational Journal of Molecular Scienceses_ES
dc.identifier.issn1422-0067-
dc.identifier.issn1661-6596-
dc.identifier.urihttps://hdl.handle.net/11000/38555-
dc.description.abstractMetabolism-disrupting chemicals (MDCs) are endocrine disruptors with obesogenic and/or diabetogenic action. There is mounting evidence linking exposure to MDCs to increased susceptibility to diabetes. Despite the important role of glucagon in glucose homeostasis, there is little information on the effects of MDCs on α-cells. Furthermore, there are no methods to identify and test MDCs with the potential to alter α-cell viability and function. Here, we used the mouse α-cell line αTC1-9 to evaluate the effects of MDCs on cell viability and glucagon secretion. We tested six chemicals at concentrations within human exposure (from 0.1 pM to 1 µM): bisphenol-A (BPA), tributyltin (TBT), perfluorooctanoic acid (PFOA), triphenylphosphate (TPP), triclosan (TCS), and dichlorodiphenyldichloroethylene (DDE). Using two different approaches, MTT assay and DNA-binding dyes, we observed that BPA and TBT decreased α-cell viability via a mechanism that depends on the activation of estrogen receptors and PPARγ, respectively. These two chemicals induced ROS production, but barely altered the expression of endoplasmic reticulum (ER) stress markers. Although PFOA, TPP, TCS, and DDE did not alter cell viability nor induced ROS generation or ER stress, all four compounds negatively affected glucagon secretion. Our findings suggest that αTC1-9 cells seem to be an appropriate model to test chemicals with metabolism-disrupting activity and that the improvement of the test methods proposed herein could be incorporated into protocols for the screening of diabetogenic MDCs.es_ES
dc.formatapplication/pdfes_ES
dc.format.extent14es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.relation.ispartofseries24es_ES
dc.relation.ispartofseries1es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectApoptosises_ES
dc.subjectDiabeteses_ES
dc.subjectEndocrine disruptorses_ES
dc.subjectGlucagon secretiones_ES
dc.subjectMetabolism-disrupting chemicalses_ES
dc.subjectPancreatic cellses_ES
dc.subjectTest methodses_ES
dc.subject.otherCDU::6 - Ciencias aplicadas::61 - Medicina::612 - Fisiologíaes_ES
dc.titleScreening of Metabolism-Disrupting Chemicals on Pancreatic α-Cells Using In Vitro Methodses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversionhttps://doi.org/10.3390/ijms24010231es_ES
Appears in Collections:
Artículos Fisiología


Thumbnail

View/Open:
 9_2023_Screening of Metabolism-Disrupting Chemicals on Pancreatic α-Cells Using In Vitro Methods_ijms-24-00231.pdf

3,22 MB
Adobe PDF
Share:


Creative Commons ???jsp.display-item.text9???